Acquisition catalyst Oncospace has been acquired by Sun Nuclear (a Mirion Medical brand), signaling potential for expanded enterprise collaborations, bundled solutions, and access to a larger customer base in radiation therapy.

Cloud first advantage Existing cloud native, AI powered planning solution hosted on Azure with SaaS delivery suggests strong upsell potential for integrated cloud based analytics, data sharing workflows, and premium support services within Mirion Medical portfolio.

Global partnerships Recent and ongoing partnerships across UK Ireland, Italy, and university collaborations indicate a proven channel pull; leverage these relationships to cross sell interoperability, data migration services, and training packages.

SMB to mid market Revenue under $1M with a small team presents focused sales motions toward mid size radiation oncology practices and single site centers seeking AI driven planning, automation features, and patient data conversion capabilities.

Expansion opportunities Post acquisition integration with Sun Nuclear opens opportunities for product line expansion, including enhanced predictive planning, data modernization services, and compliance driven solutions leveraging Microsoft, Google Cloud, and enterprise analytics capabilities.